Diverging mechanisms of activation of chemokine receptors revealed by novel chemokine agonists

Jose Sarmiento, Christie Shumate, Katsutoshi Suetomi, Aishwarya Ravindran, León Villegas, Krishna Rajarathnam, Javier Navarro

Research output: Contribution to journalArticlepeer-review

17 Scopus citations


CXCL8/interleukin-8 is a pro-inflammatory chemokine that triggers pleiotropic responses, including inflammation, angiogenesis, wound healing and tumorigenesis. We engineered the first selective CXCR1 agonists on the basis of residue substitutions in the conserved ELR triad and CXC motif of CXCL8. Our data reveal that the molecular mechanisms of activation of CXCR1 and CXCR2 are distinct: the N-loop of CXCL8 is the major determinant for CXCR1 activation, whereas the N-terminus of CXCL8 (ELR and CXC) is essential for CXCR2 activation. We also found that activation of CXCR1 cross-desensitized CXCR2 responses in human neutrophils co-expressing both receptors, indicating that these novel CXCR1 agonists represent a new class of anti-inflammatory agents. Further, these selective CXCR1 agonists will aid at elucidating the functional significance of CXCR1 in vivo under pathophysiological conditions.

Original languageEnglish (US)
Article numbere27967
JournalPloS one
Issue number12
StatePublished - Dec 9 2011

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Diverging mechanisms of activation of chemokine receptors revealed by novel chemokine agonists'. Together they form a unique fingerprint.

Cite this